Dabur India Limited recently approached the Delhi High Court to challenge a regulatory prohibition order issued by the Food Safety and Standards Authority of India (FSSAI). The controversy centers on absolute marketing statements on packaged items, bringing intense scrutiny to FSSAI food labelling claims across the Indian fast-moving consumer goods sector. FSSAI instructed Dabur to immediately halt the sale of several flagship food products that carry assertions such as 100 percent natural, pure, or organic. Consequently, this high-profile legal battle highlights the critical intersection between regulatory oversight, consumer rights, food safety standards, and clinical healthcare advice.

Dabur Legal Challenge to FSSAI Order

Dabur India filed its petition before the Delhi High Court after the food safety regulator issued a public prohibition order. Senior legal counsel mentioned the urgent matter before Chief Justice D. K. Upadhyaya and Justice Tejas Karia. Subsequently, the court scheduled the formal hearing before Justice Swarana Kanta Sharma. The corporate entity asserts that FSSAI passed the prohibition without adhering to established administrative principles. Specifically, Dabur argues that the regulator violated the principles of natural justice by failing to issue a prior show cause notice or offer a fair opportunity for a legal hearing.

Furthermore, the petition claims that FSSAI lacks explicit statutory authority to issue blanket prohibitory orders without following due administrative procedure. Dabur also noted that the regulator published the prohibition order on social media platforms before thorough adjudication. As a result, the company claims this public declaration caused significant harm to its brand image and marketplace goodwill. Furthermore, Dabur stated that numerous FMCG manufacturers routinely utilize similar marketing terminology across multiple dietary categories. Therefore, selective enforcement creates an unequal commercial environment. Nevertheless, the legal proceedings now require judicial interpretation regarding regulatory authority, consumer safety, and administrative fairness.

Understanding FSSAI Food Labelling Claims Standards

The core dispute originates from the statutory enforcement of the Food Safety and Standards (Advertising and Claims) Regulations of 2018. FSSAI maintains that absolute claims on commercial packaging are inherently ambiguous, scientifically unverifiable, and likely to mislead everyday consumers. The regulatory body identified specific products listed on Dabur's digital portals, including honey, cow ghee, virgin coconut oil, sesame oil, apple cider vinegar, coconut water, and coconut milk. These items featured descriptions such as 100 percent pure, 100 percent natural, 100 percent organic, and 100 percent purity guaranteed.

According to food regulatory standards, absolute numerical claims suggest complete freedom from all contaminants, processing variations, or natural constituents. However, achieving absolute technical purity across agricultural supply chains remains analytically non-feasible. Additionally, the regulatory authority flagged the unauthorized usage of official organic marks, such as the Jaivik Bharat logo, on certain commercial products. FSSAI directed the manufacturer to immediately cease selling the flagged items and submit an Action Taken Report within fifteen days. Consequently, these strict regulatory measures reflect a broader institutional crackdown against deceptive health claims and misleading marketing practices within the Indian food market.

Impact on Nutritional Communication and Consumer Trust

The regulatory crackdown on ambiguous packaging claims carries major implications for public health communication and consumer perception. For decades, Indian consumers relied on front-of-pack claims to guide their daily dietary selections. Marketing phrases like 100 percent pure or 100 percent natural frequently created a false perception of superior health benefits. Consequently, consumers often overlooked back-of-pack nutritional panels, ingredient lists, and added processing markers. FSSAI's direct intervention aims to eliminate deceptive labelling and encourage evidence-based consumer awareness across all consumer groups.

Furthermore, false organic or purity assertions can undermine public trust in standardized health products. When manufacturers use absolute claims without scientific verification, consumers struggle to distinguish genuine therapeutic foods from ordinary commercial goods. Therefore, transparent packaging standards protect vulnerable populations, including elderly individuals and chronic disease patients who seek specific dietary interventions. Regulatory enforcement ensures that food labels present objective, verifiable parameters rather than exaggerated commercial promises. Ultimately, standardizing health claims fosters greater accountability across the food manufacturing industry. This structural shift empowers consumers to make informed choices based on scientific nutrition facts rather than persuasive advertising narratives.

Regulatory Compliance and Natural Justice Arguments

The legal confrontation between Dabur and FSSAI raises fundamental questions regarding administrative due process and regulatory enforcement. Statutory bodies must balance public interest protection with fair legal procedures for commercial entities. Dabur's legal team emphasizes that administrative decisions must remain speaking orders, providing clear justification and objective evidence before enforcing commercial bans. The company asserts that immediate prohibition without prior notice inflicts unrecoverable commercial loss and damages long-standing corporate reputation.

Conversely, regulatory authorities argue that public health protection requires swift administrative action when misleading claims threaten consumer safety. FSSAI emphasizes that marketing regulations from 2018 explicitly prohibit misleading representations, leaving no ambiguity regarding compliance expectations. In response to regulatory observations, Dabur indicated that it had already initiated label transition processes for several products while seeking judicial clarity. However, the legal dispute underscores the necessity for clear administrative guidelines when enforcing compliance. Both corporate manufacturers and regulatory bodies require predictable frameworks to resolve disputes efficiently. As the High Court reviews the petition, the outcome will likely establish critical legal precedents governing regulatory authority, administrative fairness, and label compliance across India.

Clinical Implications for Healthcare Providers and Dietitians

Healthcare professionals, dietitians, and clinical nutritionists play a vital role in translating regulatory developments into practical patient guidance. Patients frequently consult medical practitioners regarding dietary supplements, cooking oils, honey, and natural health remedies. When commercial packaging displays absolute purity claims, patients may assume these products carry medical-grade safety or therapeutic efficacy. Therefore, clinicians must educate patients on how to interpret food labels critically rather than relying solely on front-of-pack marketing claims.

Additionally, medical practitioners should guide patients to examine mandatory back-of-pack declarations, including nutritional composition, serving sizes, ingredient lists, and regulatory licensing numbers. In clinical practice, advising patients against absolute commercial claims promotes safer dietary habits and prevents unnecessary reliance on unverified health products. Healthcare providers should also remain updated on FSSAI directives to offer accurate guidance regarding dietary safety and regulatory compliance. By fostering critical health literacy, clinicians help bridge the gap between regulatory policy and patient daily nutrition choices. Ultimately, strong regulatory oversight combined with proactive clinical communication ensures optimal public health outcomes and prevents consumer deception in dietary management.

Frequently Asked Questions

Q1: What triggered the regulatory action against Dabur by FSSAI?

The Food Safety and Standards Authority of India issued a prohibition order because Dabur marketed food products carrying misleading 100 percent claims. Flagged products included honey, cow ghee, edible oils, and coconut water. FSSAI stated that claims like 100 percent natural, pure, or organic violate 2018 advertising regulations because they are ambiguous, scientifically unverifiable, and likely to mislead general consumers.

Q2: Why did Dabur approach the Delhi High Court regarding the FSSAI ban?

Dabur filed a petition in the Delhi High Court alleging that FSSAI violated principles of natural justice. The company argued that the regulator issued a public prohibition order without sending a prior show cause notice or offering an opportunity for a fair hearing. Dabur also claimed that FSSAI lacked statutory authority for blanket prohibitory orders and that publicizing the order damaged brand image unfairly.

Q3: How do FSSAI regulations impact consumer food labelling and dietary choices?

FSSAI regulations enforce strict transparency rules to prevent misleading health and purity assertions on commercial packaging. By prohibiting absolute claims like 100 percent pure, the regulator ensures manufacturers provide verifiable nutritional information. This enforcement protects consumers from deceptive advertising and encourages individuals to read detailed back-of-pack ingredient labels for informed dietary management.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Dabur moves Delhi HC against FSSAI ban on selling food products with '100 pc'claims - ETHealthworld


2. Food Safety and Standards Authority of India. Food Safety and Standards (Advertising and Claims) Regulations, 2018. Government of India.


3. The Times of India. '100% pure'? Stop misleading products' sale, FSSAI tells Dabur. August 2026.